Related references
Note: Only part of the references are listed.Oncogenic Ras Disrupts Epithelial Integrity by Activating the Transmembrane Serine Protease Hepsin
Topi A. Tervonen et al.
CANCER RESEARCH (2021)
Hepsin: a multifunctional transmembrane serine protease in pathobiology
Shuo Li et al.
FEBS JOURNAL (2021)
Hepsin enhances liver metabolism and inhibits adipocyte browning in mice
Shuo Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies
Wei Xu et al.
BMC MEDICINE (2020)
L1CAM, CA9, KLK6, HPN, and ALDH1A1 as Potential Serum Markers in Primary and Metastatic Colorectal Cancer Screening
Francis Yew Fu Tieng et al.
DIAGNOSTICS (2020)
Hepsin Promotes Epithelial-Mesenchymal Transition and Cell Invasion Through the miR-222/ PPP2R2A/AKT Axis in Prostate Cancer
Ruiqian Li et al.
ONCOTARGETS AND THERAPY (2020)
Prostasin and hepatocyte growth factor B in factor VIIa generation: Serine protease knockdowns in zebrafish
Gauri Khandekar et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management
Marwa S. Hamza et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)
Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer
Qingyang Feng et al.
CLINICAL CANCER RESEARCH (2019)
Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells
Ramona Willbold et al.
CELL DEATH & DISEASE (2019)
Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study
Dakui Luo et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2018)
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
Norbaini Binti Abdol Razak et al.
CANCERS (2018)
The role of type II transmembrane serine protease-mediated signaling in cancer
Lauren M. Tanabe et al.
FEBS JOURNAL (2017)
The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover
David J. Wilkinson et al.
SCIENTIFIC REPORTS (2017)
Type II transmembrane serine proteases as potential targets for cancer therapy
Andrew S. Murray et al.
BIOLOGICAL CHEMISTRY (2016)
High Hepsin expression predicts poor prognosis in Gastric Cancer
Mingming Zhang et al.
SCIENTIFIC REPORTS (2016)
Clinical and Biological Significance of Hepsin Overexpression in Breast Cancer
Peng Xing et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives
Markus Rentsch et al.
VISCERAL MEDICINE (2016)
Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
Mikko Pelkonen et al.
BMC CANCER (2015)
Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients
Rodrigo Dienstmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals
Jianing Li et al.
LIFETIME DATA ANALYSIS (2015)
Impact of proteolytic enzymes in colorectal cancer development and progression
Laszlo Herszenyi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study
Boris Dickmann et al.
HAEMATOLOGICA (2013)
Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study
M. T. Stender et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Impact of Preoperative Thrombocytosis on the Survival of Patients with Primary Colorectal Cancer
Kazuhito Sasaki et al.
WORLD JOURNAL OF SURGERY (2012)
A Note on Variance Estimation of the Aalen-Johansen Estimator of the Cumulative Incidence Function in Competing Risks, with a View towards Left-Truncated Data
Arthur Allignol et al.
BIOMETRICAL JOURNAL (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
High Preoperative Plasma Fibrinogen Levels Are Associated With Distant Metastases and Impaired Prognosis After Curative Resection in Patients With Colorectal Cancer
Liang Tang et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Hepsin Cooperates With MYC in the Progression of Adenocarcinoma in a Prostate Cancer Mouse Model
Srinivas Nandana et al.
PROSTATE (2010)
Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model
Jiangyong Miao et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Laminin-332 Is a Substrate for Hepsin, a Protease Associated with Prostate Cancer Progression
Manisha Tripathi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Choice and interpretation of statistical tests used when competing risks are present
James J. Dignam et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases
Colm Morrissey et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Hepsin inhibits the cell growth of endometrial cancer
Keiichiro Nakamura et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2008)
Hepsin and prostate cancer
Qingyu Wu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Venous thromboembolism in patients with colorectal cancer: Incidence and effect on survival
A Alcalay et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma
Wei-Shu Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Hepsin promotes prostate cancer progression and metastasis
O Klezovitch et al.
CANCER CELL (2004)
Hepsin paradox reveals unexpected complexity of metastatic process
V Vasioukhin
CELL CYCLE (2004)
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer
C Stephan et al.
JOURNAL OF UROLOGY (2004)
Share Paper
